- Exchange: NYSE MKT LLC
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Actinium Pharmaceuticals Inc+ Add to Watchlist
ATNM:US7.0200 USD 0.0200 0.28%
As of 09:55:18 ET on 07/25/2014.
Company Profile for Actinium Pharmaceuticals Inc (ATNM)
Actinium Pharmaceuticals Inc. operates as a biopharmaceutical company. The Company develops alpha particle immunotherapeutics and other radiopharmaceuticals for select applications.
Actinium Pharmaceuticals Inc
Key Executives for Actinium Pharmaceuticals Inc (ATNM)
|Kaushik J DavePresident/CEO/Interim CFO||Dragan CicicCOO/Chief Medical Officer|